Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas.
Saved in:
| Title: | Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas. |
|---|---|
| Authors: | Welling DB; Department of Otolaryngology Head and Neck Surgery Harvard Medical School, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital Boston Massachusetts USA., Collier KA; Division of Medical Oncology, Department of Internal Medicine The Ohio State University College of Medicine and the Comprehensive Cancer Center Columbus Ohio USA., Burns SS; Center for Childhood Cancer and Blood diseases Abigail Wexner Research Institute at Nationwide Children's Hospital Columbus Ohio USA.; Department of Pediatrics The Ohio State University College of Medicine Columbus Ohio USA., Oblinger JL; Center for Childhood Cancer and Blood diseases Abigail Wexner Research Institute at Nationwide Children's Hospital Columbus Ohio USA.; Department of Pediatrics The Ohio State University College of Medicine Columbus Ohio USA., Shu E; Department of Otolaryngology Head and Neck Surgery Harvard Medical School, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital Boston Massachusetts USA., Miles-Markley BA; Department of Otolaryngology-Head and Neck Surgery The Ohio State University College of Medicine Columbus Ohio USA., Hofmeister CC; Department of Hematology & Oncology Winship Cancer Institute of Emory University Atlanta Georgia USA., Makary MS; Department of Radiology The Ohio State University College of Medicine Columbus Ohio USA., Slone HW; Department of Radiology The Ohio State University College of Medicine Columbus Ohio USA., Blakeley JO; Departments of Neurology, Neurosurgery, & Oncology Johns Hopkins University Baltimore Maryland USA., Mansouri SA; Departments of Neurology, Neurosurgery, & Oncology Johns Hopkins University Baltimore Maryland USA., Neff BA; Department of Otolaryngology Head and Neck Surgery Mayo Clinic Rochester Minnesota USA., Jackler RK; Department of Otolaryngology Head and Neck Surgery Stanford University Palo Alto California USA., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine The Ohio State University College of Medicine and the Comprehensive Cancer Center Columbus Ohio USA., Chang LS; Center for Childhood Cancer and Blood diseases Abigail Wexner Research Institute at Nationwide Children's Hospital Columbus Ohio USA.; Department of Pediatrics The Ohio State University College of Medicine Columbus Ohio USA.; Department of Otolaryngology-Head and Neck Surgery The Ohio State University College of Medicine Columbus Ohio USA. |
| Source: | Laryngoscope investigative otolaryngology [Laryngoscope Investig Otolaryngol] 2021 Aug 20; Vol. 6 (5), pp. 1008-1019. Date of Electronic Publication: 2021 Aug 20 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101684963 Publication Model: eCollection Cited Medium: Print ISSN: 2378-8038 (Print) Linking ISSN: 23788038 NLM ISO Abbreviation: Laryngoscope Investig Otolaryngol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
